Clinical trials: Outpatients / Inpatients With Depression
Outpatients / Inpatients With Depression
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
This study is a multicenter clinical research and focuses on the exploring of optimal diagnosis and treatment strategies of MDD based on anhedonia.
- Trial name
- NCT05389046
- Testing
- Escitalopram, Escitalopram+Aripiprazole, Escitalopram+omega-3 PUFAs
- Where
- 3 sites in China
- Volunteers
- 252 people
- Sponsor
- Peking University
Outpatients or Inpatients With Depression
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
To observe the efficacy and safety of Shugan Jieyu Capsules in treating patients with varying degrees of depression in real-world clinical settings, and to provide data references for optimizing integrated traditional Chinese and…
- Trial name
- NCT07785284
- Testing
- Shugan Jieyu Capsules
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Peking University
Outpatients / Inpatients With Depression
A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression
This study mainly evaluates the efficacy and safety of Shuganjieyu capsule combined with Fluoxetine as well as the Fluoxetine monotherapy for the treatment of depression in the basic study, and also explores the efficacy for the…
- Trial name
- NCT05361330
- Testing
- Shuganjieyu capsule, Fluoxetine
- Where
- 3 sites in China
- Volunteers
- 160 people
- Sponsor
- Peking University